Biotransformation of 5(10)-estrene-3 alpha,17 beta-diol by equine testicular preparations in vitro.

The research investigates the biosynthesis of a particular isomer called 5(10)-estrene-3 alpha, 17 beta-diol in stallion testes and how it affects the formation of 19-nor steroids and oestrogens.

Summary of the Study and Its Context

• This study examines the biosynthesis process as it pertains specifically to 5(10)-estrene-3 alpha,17 beta-diol in stallion testes, and how these biosynthetic processes could influence the formation of various types of steroids.
• Previous research cited in this paper reveal that 19-nor steroids, which are a type of neutral steroid, have been previously identified in stallion urine and testes, and the creation of an isomer of 5(10)-estrene-3,17-diol from certain precursors by stallion testicular tissue had also been reported.
• The mechanism proposed for the formation of 5(10)-estrene steroids involves the retro-aldol type elimination of HCHO or HCOOH from 19-hydroxyandrost-4-en-3-one androgens which are present in significant amounts in stallion testes.

Proposed Mechanism for 19-nor Steroids Aromatization

• In addition to the mechanism for the formation of 5(10)-estrene steroids, the paper also refers to the conversion of 19-nor steroids to oestrogens, which has been reported both in vivo and in vitro.
• The proposed mechanism for this aromatization of 19-nor steroids is thought to occur via the formation and subsequent dehydration of 1-hydroxylated intermediates.

Role of 5(10)-estrene-3.17-diols

• Given the relatively high levels of the conjugated 5(10)-estrene-3.17-diols in stallion urine and testes, there are questions raised in this paper about whether these substances are formed as non-aromatic by-products during oestrogen biosynthesis. The paper also questions if these substances play a role as intermediates in the biosynthesis of other C18 neutral and phenolic steroids.
• In order to clarify these questions, the study engages in an exploration of the biotransformation of 5(10)-estrene-3 alpha,17 beta-diol, conducting these investigations in vitro with the use of stallion testes preparations in a phosphate buffer.
• To further support the research process, an NADPH generating system is engaged.